Nkarta CEO Paul Hastings on NK based cell therapies for autoimmune conditions
- blonca9
- Mar 27, 2024
- 1 min read
He describes why Nkarta believes NK cells are uniquely suited for the job.
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.